Cubist Pharmaceuticals Inc (CBST) financial statements (2021 and earlier)

Company profile

Business Address 65 HAYDEN AVENUE
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments687643566579921891853
Cash and cash equivalents2342221029153920563
Short-term investments453422464488383685790
Receivables11510710112310610293
Inventory, net of allowances, customer advances and progress billings69605858555243
Inventory69605858555243
Prepaid expense and other current assets825146
Deferred tax assets47668552381818
Other undisclosed current assets55645958   
Total current assets:9729418688701,2031,1131,052
Noncurrent Assets
Property, plant and equipment183180177178170168166
Long-term investments and receivables    7711088
Long-term investments    7711088
Intangible assets, net (including goodwill)1,7041,7331,0881,104411257262
Goodwill382383383383274114114
Intangible assets, net (excluding goodwill)1,3221,350705721137143148
Other noncurrent assets879010398   
Prepaid expense and other noncurrent assets746164
Other undisclosed noncurrent assets237237896896932273273
Total noncurrent assets:2,2112,2402,2642,2761,663869854
TOTAL ASSETS:3,1833,1813,1323,1462,8661,9821,905
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities198257210277197188156
Accounts payable30343732363032
Accrued liabilities168223174245161158123
Deferred revenue and credits7776766
Other liabilities6667444
Other undisclosed current liabilities64636220 3939
Total current liabilities:275332285311208237204
Noncurrent Liabilities
Long-term debt and lease obligation8438358261,041810375371
Long-term debt, excluding current maturities8438358261,041810375371
Liabilities, other than long-term debt440441462437328171178
Deferred revenue and credits27283031323234
Deferred tax liabilities, net36436338435825294100
Liability for uncertainty in income taxes19181616161515
Other liabilities30333232283030
Other undisclosed noncurrent liabilities8585112(37)145139137
Total noncurrent liabilities:1,3691,3611,4001,4411,283686687
Total liabilities:1,6441,6931,6851,7521,491923891
Stockholders' equity
Stockholders' equity attributable to parent1,5401,4881,4471,3941,3761,0591,015
Common stock0000000
Additional paid in capital1,4391,4081,3921,3621,338989959
Accumulated other comprehensive income (loss)(2)0000(1)(0)
Retained earnings102795531377156
Total stockholders' equity:1,5401,4881,4471,3941,3761,0591,015
TOTAL LIABILITIES AND EQUITY:3,1833,1813,1323,1462,8661,9821,905

Income statement (P&L) ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Revenues309294261300266259230
Revenue, net(58)(42)(41)(42)(25)(28)(28)
Cost of revenue
(Cost of Goods and Services Sold)
(95)(89)(74)(81)(61)(63)(56)
Gross profit:214206188219205196174
Operating expenses(172)(206)(209)(306)(204)(170)(168)
Other undisclosed operating income26425071333
Operating income (loss):684228(16)42810
Nonoperating expense(14)(14)(14)(14)(43)(7)(6)
Other nonoperating income (expense)00(0)(0)(35)(0)0
Interest and debt expense(15)(15)(14)(14)(9)(7)(7)
Other undisclosed income from continuing operations before equity method investments, income taxes  1414977
Income (loss) from continuing operations before equity method investments, income taxes:391414(30)(39)214
Other undisclosed income from continuing operations before income taxes1515     
Income (loss) from continuing operations before income taxes:542814(30)(39)214
Income tax expense (benefit)(31)(4)10245(6)2
Net income (loss) available to common stockholders, basic:232424(6)(34)156
Other undisclosed net income available to common stockholders, diluted222    
Net income (loss) available to common stockholders, diluted:252626(6)(34)156

Comprehensive Income ($ in millions)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net income (loss):232424(6)(34)156
Comprehensive income (loss):232424(6)(34)156
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2)(0)001(0)0
Comprehensive income (loss), net of tax, attributable to parent:212424(6)(33)156

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: